| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.52 | 0.05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.05 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.06 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.06 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.099 | 0.06 |